03Recent Activity
Participated in Epoch Biodesign's $18.3M Series A for synthetic biology and biotechnology.
MAR 5, 2025
Participated in Epoch Biodesign's $18.3M Series A led by Extantia Capital for enzymatic plastic recycling.
MAR 2025
Epoch Biodesign produces virgin-quality, recycled polymers with ultra-low emissions, starting with nylon 6,6
Epoch Biodesign produces virgin-quality, recycled polymers with ultra-low emissions, starting with nylon 6,6. The company uses biology to transform waste into recycled, drop-in materials at low temperatures and low cost, leveraging AI technology to design enzymes that deconstruct materials at the molecular level.